{"id":"ecabet-3-70","safety":{"commonSideEffects":[{"rate":"null","effect":"Headache"},{"rate":"null","effect":"Diarrhea"},{"rate":"null","effect":"Nausea"}]},"_chembl":{"chemblId":"CHEMBL2104585","moleculeType":"Small molecule","molecularWeight":"380.51"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Ecabet works by enhancing the protective functions of the gastric mucosa, thereby reducing the risk of gastric ulcers and other gastrointestinal damage. It does this by increasing the production of prostaglandins, which help to maintain the integrity of the gastric mucosa.","oneSentence":"Ecabet is a gastroprotective agent that acts as a mucosal protective agent.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T02:36:26.311Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Gastroprotection in patients with gastric ulcers"}]},"trialDetails":[{"nctId":"NCT00370747","phase":"PHASE2","title":"Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome","status":"COMPLETED","sponsor":"Bausch & Lomb Incorporated","startDate":"2006-09","conditions":"Dry Eye Syndromes","enrollment":162},{"nctId":"NCT00198536","phase":"PHASE2, PHASE3","title":"Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome","status":"COMPLETED","sponsor":"Bausch & Lomb Incorporated","startDate":"2005-04","conditions":"Dry Eye Syndromes","enrollment":159}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Ecabet 3.70%","genericName":"Ecabet 3.70%","companyName":"Bausch & Lomb Incorporated","companyId":"bausch-lomb-incorporated","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ecabet is a gastroprotective agent that acts as a mucosal protective agent. Used for Gastroprotection in patients with gastric ulcers.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}